CompletedN/ALSD

LSD-Perceptual-Choice-Study

Sponsored by University Hospital, Basel, Switzerland

NCT ID
NCT05976698
Target Enrollment
30 participants
Start Date
2024-02-26
Est. Completion
2025-02-25

About This Study

The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.

Conditions Studied

LSD Reaction

Interventions

  • LSD 10 μg
  • LSD 20 μg
  • Placebo

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Willingness to adhere to the study protocol and sign the consent form
* ≥ 18 and ≤ 65 years of age at Screening
* Body mass index 18-29
* Fluent understanding of German
* Normal or corrected-to-normal vision
* Willingness to not operate a traffic vehicle or heavy machinery 24 hours after substance administration
* Willingness to refrain from taking illicit psychoactive substances, including cannabis, for the duration of the study
* Willingness to not consume more than one alcoholic standard drink the night before the study sessions and not consume alcohol for 24 h after each study session
* Willingness to abstain from xanthine-based liquids from the evenings prior to the study sessions and during the sessions
* Willingness to use effective birth-control throughout the study duration
* Adequate task performance in the decision-making tasks during a practice session in the screening visit

Exclusion Criteria:

* Recent (\<30 days) or current participation in another clinical trial
* Women that are pregnant, nursing, or planning to become pregnant during the study period
* Current use of contraindicated/psychoactive medications or illicit drugs
* Lifetime use of classical psychedelics more than 20 times, or any time within the previous two months
* Consumption of \>5 cigarettes per day or \>20 alcoholic standard drinks per week
* Severe chronic or acute medical condition
* Hypertension (\>140/90 mmHg) or hypotension (\<85mmHg systolic)
* Current or lifetime major mental health disorder
* Personal or family (first-degree) history of a primary psychotic disorder

Study Locations (1)

University Psychiatric Clinics Basel
Basel, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

LSD-Perceptual-Choice-Study | Huxley